Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Miyarisan Pharmaceutical Co., Ltd. (Japan)
Homepage:
miyarisan.com
Alternate names:
Miyarisan Pharmaceutical,
Miyarisan Pharmaceutical Co., Ltd.,
みやりさん製薬,
ミヤリサン製薬株式会社
ROR:
01y03pr95
OpenAlex ID:
I4405271135
The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis
2020
·
Sho Kitamoto
, Hiroko Nagao-Kitamoto
, et al.
·
Cell
·
723
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
2022
·
Nazli Dizman
, Luis Meza
, et al.
·
Nature Medicine
·
542
PDF
Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis
2019
·
Nobuhiro Nakamoto
, Nobuo Sasaki
, et al.
·
Nature Microbiology
·
448
A Single Strain of Clostridium butyricum Induces Intestinal IL-10-Producing Macrophages to Suppress Acute Experimental Colitis in Mice
2013
·
Atsushi Hayashi
, Toshiro Sato
, et al.
·
Cell Host & Microbe
·
348
PDF
Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Insight into the Probiotics for the Gut-Liver Axis
2013
·
Hitoshi Endo
, Maki Niioka
, et al.
·
PLoS ONE
·
343
PDF
The liver–brain–gut neural arc maintains the Treg cell niche in the gut
2020
·
Toshiaki Teratani
, Yohei Mikami
, et al.
·
Nature
·
275
Smad2 and Smad3 Inversely Regulate TGF-β Autoinduction in Clostridium butyricum-Activated Dendritic Cells
2015
·
Ikkou Kashiwagi
, Rimpei Morita
, et al.
·
Immunity
·
201
PDF
An organoid-based organ-repurposing approach to treat short bowel syndrome
2021
·
Shinya Sugimoto
, Eiji Kobayashi
, et al.
·
Nature
·
196
Clostridium butyricum Modulates the Microbiome to Protect Intestinal Barrier Function in Mice with Antibiotic-Induced Dysbiosis
2019
·
Mao Hagihara
, Yasutoshi Kuroki
, et al.
·
iScience
·
167
PDF
Dietary l-serine confers a competitive fitness advantage to Enterobacteriaceae in the inflamed gut
2019
·
Sho Kitamoto
, Christopher J. Alteri
, et al.
·
Nature Microbiology
·
166
A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease
2015
·
Takanori Kanai
, Yohei Mikami
, et al.
·
Journal of Gastroenterology
·
165
PDF
The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis
2015
·
Asuka Yasueda
, Tsunekazu Mizushima
, et al.
·
Surgery Today
·
145
Intestinal Dysbiosis and Biotin Deprivation Induce Alopecia through Overgrowth of Lactobacillus murinus in Mice
2017
·
Atsushi Hayashi
, Yohei Mikami
, et al.
·
Cell Reports
·
137
PDF
IL-10 produced by macrophages regulates epithelial integrity in the small intestine
2019
·
Tina L. Morhardt
, Atsushi Hayashi
, et al.
·
Scientific Reports
·
131
PDF
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
2024
·
Hedyeh Ebrahimi
, Nazli Dizman
, et al.
·
Nature Medicine
·
121
PDF
Development of a Scalable Coculture System for Gut Anaerobes and Human Colon Epithelium
2020
·
Nobuo Sasaki
, Kentaro Miyamoto
, et al.
·
Gastroenterology
·
110
Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors
2022
·
Yusuke Tomita
, Yoshihiko Goto
, et al.
·
OncoImmunology
·
109
PDF
Oral microbiome alterations of healthy volunteers with proton pump inhibitor
2017
·
Tsuyoshi Mishiro
, Kentaro Oka
, et al.
·
Journal of Gastroenterology and Hepatology
·
103
Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain
2011
·
Timothy D. H. Woo
, Kentaro Oka
, et al.
·
Journal of Medical Microbiology
·
103
Clostridium Butyricum MIYAIRI 588 Improves High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats
2013
·
Makoto Seo
, Ikuo Inoue
, et al.
·
Digestive Diseases and Sciences
·
99
Regulation of Toxin Production in Clostridium perfringens
2016
·
Kaori Ohtani
, Tohru Shimizu
·
Toxins
·
97
PDF
Flagellin-mediated activation of IL-33-ST2 signaling by a pathobiont promotes intestinal fibrosis
2019
·
Jin Imai
, Sho Kitamoto
, et al.
·
Mucosal Immunology
·
93
PDF
A potential pathogenic association between periodontal disease and Crohn’s disease
2021
·
Jin Imai
, Hitoshi Ichikawa
, et al.
·
JCI Insight
·
91
PDF
Molecular and Microbiological Characterization of Clostridium difficile Isolates from Single, Relapse, and Reinfection Cases
2011
·
Kentaro Oka
, Takako Osaki
, et al.
·
Journal of Clinical Microbiology
·
91
The Butyrate-Producing Bacterium Clostridium butyricum Suppresses Clostridioides difficile Infection via Neutrophil- and Antimicrobial Cytokine–Dependent but GPR43/109a-Independent Mechanisms
2021
·
Atsushi Hayashi
, Hiroko Nagao-Kitamoto
, et al.
·
The Journal of Immunology
·
90
Show more works
View as search
Works count:
163
Citation count:
17,000
Year
Topic
Type
